Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $0.16 in the prior trading day, Oncology Institute Inc (NASDAQ: TOI) closed at $0.15, down -0.65%. In other words, the price has decreased by -$0.65 from its previous closing price. On the day, 7.01 million shares were traded. TOI stock price reached its highest trading level at $0.1669 during the session, while it also had its lowest trading level at $0.1455.
Ratios:
Our goal is to gain a better understanding of TOI by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.27 and its Current Ratio is at 2.49. In the meantime, Its Debt-to-Equity ratio is 7.94 whereas as Long-Term Debt/Eq ratio is at 7.51.
On September 14, 2022, Guggenheim started tracking the stock assigning a Buy rating and target price of $7.
On August 15, 2022, Jefferies started tracking the stock assigning a Buy rating and target price of $10.Jefferies initiated its Buy rating on August 15, 2022, with a $10 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 29 ’24 when Havencrest Healthcare Partners sold 8,637 shares for $2.12 per share. The transaction valued at 18,310 led to the insider holds 0 shares of the business.
Havencrest Healthcare Partners sold 24,915 shares of TOI for $57,304 on Jan 24 ’24. The 10% Owner now owns 27,498 shares after completing the transaction at $2.30 per share. On Jan 25 ’24, another insider, Havencrest Healthcare Partners, who serves as the 10% Owner of the company, sold 11,882 shares for $2.07 each. As a result, the insider received 24,596 and left with 15,616 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TOI now has a Market Capitalization of 11651214 and an Enterprise Value of 92398360. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.03 while its Price-to-Book (P/B) ratio in mrq is 0.75. Its current Enterprise Value per Revenue stands at 0.256 whereas that against EBITDA is -1.611.
Stock Price History:
Over the past 52 weeks, TOI has reached a high of $2.50, while it has fallen to a 52-week low of $0.13. The 50-Day Moving Average of the stock is -46.99%, while the 200-Day Moving Average is calculated to be -79.59%.
Shares Statistics:
The stock has traded on average 714.12K shares per day over the past 3-months and 4765200 shares per day over the last 10 days, according to various share statistics. A total of 74.15M shares are outstanding, with a floating share count of 37.08M. Insiders hold about 50.93% of the company’s shares, while institutions hold 22.59% stake in the company. Shares short for TOI as of 1730332800 were 247975 with a Short Ratio of 0.35, compared to 1727654400 on 252527. Therefore, it implies a Short% of Shares Outstanding of 247975 and a Short% of Float of 0.5.
